

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.86647406 |
| 2 | regulation of RIG-I signaling pathway (GO:0039535) | 5.74582814 |
| 3 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.68831768 |
| 4 | regulation of activation of Janus kinase activity (GO:0010533) | 5.64141884 |
| 5 | * cellular response to type I interferon (GO:0071357) | 5.62072182 |
| 6 | * type I interferon signaling pathway (GO:0060337) | 5.62072182 |
| 7 | * response to type I interferon (GO:0034340) | 5.55327736 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 5.49709133 |
| 9 | response to interferon-alpha (GO:0035455) | 5.18877928 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 5.15049974 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.07132282 |
| 12 | T-helper 1 type immune response (GO:0042088) | 5.02349073 |
| 13 | positive regulation of type 2 immune response (GO:0002830) | 4.85830450 |
| 14 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.85083566 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 4.63162002 |
| 16 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.60748775 |
| 17 | positive regulation of interleukin-12 production (GO:0032735) | 4.60142219 |
| 18 | neutrophil activation (GO:0042119) | 4.57820334 |
| 19 | granulocyte activation (GO:0036230) | 4.51178408 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.48380970 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.44078670 |
| 22 | negative regulation of cell killing (GO:0031342) | 4.44078670 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.43734182 |
| 24 | * negative regulation of viral genome replication (GO:0045071) | 4.38185353 |
| 25 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.34489285 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.26715940 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.26715940 |
| 28 | cellular response to interferon-beta (GO:0035458) | 4.22111748 |
| 29 | myeloid dendritic cell differentiation (GO:0043011) | 4.19429761 |
| 30 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.17244422 |
| 31 | natural killer cell mediated immunity (GO:0002228) | 4.17244422 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 4.14720720 |
| 33 | positive regulation of interleukin-17 production (GO:0032740) | 4.12862799 |
| 34 | cellular response to interferon-alpha (GO:0035457) | 4.12706352 |
| 35 | positive regulation of T cell cytokine production (GO:0002726) | 4.12426813 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.11464711 |
| 37 | response to peptidoglycan (GO:0032494) | 4.11271207 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.03855106 |
| 39 | cellular response to exogenous dsRNA (GO:0071360) | 3.99655945 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97042751 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 3.97042751 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97042751 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97042751 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97042751 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.97042751 |
| 46 | cellular response to virus (GO:0098586) | 3.96061600 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.91037027 |
| 48 | positive regulation of response to biotic stimulus (GO:0002833) | 3.90826183 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 3.89691888 |
| 50 | regulation of immunoglobulin secretion (GO:0051023) | 3.88951351 |
| 51 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.87507238 |
| 52 | defense response to protozoan (GO:0042832) | 3.87291568 |
| 53 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.85430450 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.84611867 |
| 55 | negative regulation of interleukin-17 production (GO:0032700) | 3.81866311 |
| 56 | myeloid dendritic cell activation (GO:0001773) | 3.80082954 |
| 57 | * regulation of viral genome replication (GO:0045069) | 3.76251330 |
| 58 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.72859504 |
| 59 | B cell mediated immunity (GO:0019724) | 3.68246342 |
| 60 | detection of other organism (GO:0098543) | 3.68152050 |
| 61 | detection of bacterium (GO:0016045) | 3.65806799 |
| 62 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.63868615 |
| 63 | natural killer cell activation involved in immune response (GO:0002323) | 3.63830700 |
| 64 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.62857586 |
| 65 | response to interferon-beta (GO:0035456) | 3.60236019 |
| 66 | regulation of interleukin-17 production (GO:0032660) | 3.60105602 |
| 67 | regulation of natural killer cell differentiation (GO:0032823) | 3.59579532 |
| 68 | * negative regulation of viral process (GO:0048525) | 3.57255988 |
| 69 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.57175102 |
| 70 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56062755 |
| 71 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55484575 |
| 72 | positive regulation of defense response to virus by host (GO:0002230) | 3.55210093 |
| 73 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.54577849 |
| 74 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.54522269 |
| 75 | monocyte chemotaxis (GO:0002548) | 3.52386344 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 3.50331727 |
| 77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.49667672 |
| 78 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.49084134 |
| 79 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.49084134 |
| 80 | cellular response to zinc ion (GO:0071294) | 3.48236473 |
| 81 | regulation of interleukin-12 production (GO:0032655) | 3.47775646 |
| 82 | regulation of defense response to virus by host (GO:0050691) | 3.46339416 |
| 83 | regulation of type 2 immune response (GO:0002828) | 3.44113388 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.43532936 |
| 85 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43246059 |
| 86 | * defense response to virus (GO:0051607) | 3.40577339 |
| 87 | striated muscle atrophy (GO:0014891) | 3.39802351 |
| 88 | response to muramyl dipeptide (GO:0032495) | 3.39703244 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.36287875 |
| 90 | germinal center formation (GO:0002467) | 3.35906069 |
| 91 | regulation of hypersensitivity (GO:0002883) | 3.35631203 |
| 92 | response to exogenous dsRNA (GO:0043330) | 3.34820407 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.34147902 |
| 94 | response to host immune response (GO:0052572) | 3.34147902 |
| 95 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.33576778 |
| 96 | regulation of antigen processing and presentation (GO:0002577) | 3.33090255 |
| 97 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.32957452 |
| 98 | cellular response to interferon-gamma (GO:0071346) | 3.32951071 |
| 99 | response to host (GO:0075136) | 3.32436119 |
| 100 | response to host defenses (GO:0052200) | 3.32436119 |
| 101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32436119 |
| 102 | dendritic cell differentiation (GO:0097028) | 3.31333490 |
| 103 | natural killer cell differentiation (GO:0001779) | 3.30398136 |
| 104 | regulation of memory T cell differentiation (GO:0043380) | 3.29653734 |
| 105 | positive regulation of natural killer cell activation (GO:0032816) | 3.29395947 |
| 106 | regulation of T-helper cell differentiation (GO:0045622) | 3.29237116 |
| 107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.27578335 |
| 108 | lymphocyte chemotaxis (GO:0048247) | 3.27401372 |
| 109 | eosinophil chemotaxis (GO:0048245) | 3.26971084 |
| 110 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.25477163 |
| 111 | B cell proliferation (GO:0042100) | 3.22888743 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.21452342 |
| 113 | detection of external biotic stimulus (GO:0098581) | 3.20279903 |
| 114 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.20005623 |
| 115 | macrophage activation involved in immune response (GO:0002281) | 3.18145391 |
| 116 | response to protozoan (GO:0001562) | 3.17552029 |
| 117 | regulation of interferon-beta production (GO:0032648) | 3.15280978 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 3.14290609 |
| 119 | positive regulation of humoral immune response (GO:0002922) | 3.12832984 |
| 120 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12724621 |
| 121 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.12550592 |
| 122 | natural killer cell activation (GO:0030101) | 3.12499358 |
| 123 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11882553 |
| 124 | B cell receptor signaling pathway (GO:0050853) | 3.11682345 |
| 125 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.11094477 |
| 126 | negative regulation of type I interferon production (GO:0032480) | 3.10683565 |
| 127 | leukocyte mediated cytotoxicity (GO:0001909) | 3.08649989 |
| 128 | negative regulation of innate immune response (GO:0045824) | 3.07902381 |
| 129 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.06747732 |
| 130 | regulation of mononuclear cell migration (GO:0071675) | 3.06489686 |
| 131 | T cell migration (GO:0072678) | 3.06254063 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 3.05568397 |
| 133 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.04731731 |
| 134 | negative regulation of type 2 immune response (GO:0002829) | 3.04418175 |
| 135 | regulation of T cell tolerance induction (GO:0002664) | 3.03682231 |
| 136 | response to interferon-gamma (GO:0034341) | 3.03604555 |
| 137 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.96923201 |
| 138 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.95192532 |
| 139 | negative thymic T cell selection (GO:0045060) | 2.94638516 |
| 140 | interferon-gamma secretion (GO:0072643) | 2.91413356 |
| 141 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91163547 |
| 142 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.87751564 |
| 143 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.87470330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.39571616 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.63465900 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.80506618 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.99566804 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.19579899 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33821349 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.19728770 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32718728 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16766225 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.15927369 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.02799774 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.02383528 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92540990 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.76391441 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54712492 |
| 16 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54480910 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29390322 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.22934079 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.09178800 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98765673 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95011065 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 1.68202965 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64578721 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62153752 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57144272 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56210951 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55269274 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53871468 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52774212 |
| 30 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50953355 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46500760 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.43045833 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39203816 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38752496 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37736898 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37369124 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35750128 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.35147136 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33277908 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32174729 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31896867 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30716755 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29455054 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26663653 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25970971 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24510222 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23699654 |
| 48 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18211353 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17803939 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13934774 |
| 51 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10076042 |
| 52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09945583 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08646043 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08623979 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08065821 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06530856 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05195184 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05038980 |
| 59 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03681059 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03619918 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03429656 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03170143 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02999523 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02399121 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00851098 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99503283 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97092096 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93638550 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93268142 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89568961 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87541505 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87446534 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85218136 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84092406 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83558027 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82074899 |
| 77 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.81139321 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80130881 |
| 79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78843752 |
| 80 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.78175088 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77829192 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77829192 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77787887 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77342827 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75671183 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74796343 |
| 87 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.74785489 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73986236 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72722057 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72491412 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72282725 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71102270 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.70128468 |
| 94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69131371 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.68317785 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68030854 |
| 97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66873406 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.66478822 |
| 99 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66371403 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65976238 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64048654 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64004439 |
| 103 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.63889845 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62355531 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 0.62300366 |
| 106 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.61822276 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61802600 |
| 108 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.61684002 |
| 109 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.61388149 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60193583 |
| 111 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.58674679 |
| 112 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.57651693 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.56748439 |
| 114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.56479694 |
| 115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.56127143 |
| 116 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.56127143 |
| 117 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.54805433 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54176837 |
| 119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.53766038 |
| 120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.53325579 |
| 121 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.53037507 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.52623631 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.52353212 |
| 124 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.51687939 |
| 125 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.51360637 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.51029498 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.49889252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.53828420 |
| 2 | * MP0009785_altered_susceptibility_to | 4.28187274 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 4.22482722 |
| 4 | MP0000685_abnormal_immune_system | 3.97516965 |
| 5 | MP0001790_abnormal_immune_system | 3.71578121 |
| 6 | MP0005387_immune_system_phenotype | 3.71578121 |
| 7 | MP0003436_decreased_susceptibility_to | 3.49383895 |
| 8 | MP0004510_myositis | 3.45453683 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.17978815 |
| 10 | MP0005671_abnormal_response_to | 3.16235363 |
| 11 | * MP0005025_abnormal_response_to | 3.12264788 |
| 12 | MP0006082_CNS_inflammation | 2.87112876 |
| 13 | MP0002419_abnormal_innate_immunity | 2.86695680 |
| 14 | MP0003724_increased_susceptibility_to | 2.83409110 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.72877482 |
| 16 | MP0002723_abnormal_immune_serum | 2.69899102 |
| 17 | MP0001800_abnormal_humoral_immune | 2.67293783 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.42226579 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.39194112 |
| 20 | MP0001819_abnormal_immune_cell | 2.35002970 |
| 21 | MP0003303_peritoneal_inflammation | 2.29839554 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.25162585 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.25137495 |
| 24 | MP0009840_abnormal_foam_cell | 2.20144729 |
| 25 | MP0009764_decreased_sensitivity_to | 2.12028837 |
| 26 | MP0001348_abnormal_lacrimal_gland | 2.03881899 |
| 27 | MP0002163_abnormal_gland_morphology | 2.02741387 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 2.02507432 |
| 29 | MP0001853_heart_inflammation | 2.02138883 |
| 30 | MP0005310_abnormal_salivary_gland | 2.00871536 |
| 31 | MP0002006_tumorigenesis | 1.99913129 |
| 32 | MP0002254_reproductive_system_inflammat | 1.97556272 |
| 33 | MP0004782_abnormal_surfactant_physiolog | 1.84990951 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.78197018 |
| 35 | MP0004947_skin_inflammation | 1.77145866 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.75464336 |
| 37 | MP0002405_respiratory_system_inflammati | 1.73514372 |
| 38 | * MP0000716_abnormal_immune_system | 1.71911159 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.69327178 |
| 40 | MP0005451_abnormal_body_composition | 1.67212029 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.66995824 |
| 42 | MP0008469_abnormal_protein_level | 1.65425461 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.64794825 |
| 44 | MP0002398_abnormal_bone_marrow | 1.61170929 |
| 45 | MP0003448_altered_tumor_morphology | 1.54504854 |
| 46 | MP0001346_abnormal_lacrimal_gland | 1.50955994 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.46192786 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.40581535 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.29317522 |
| 50 | * MP0002429_abnormal_blood_cell | 1.28676399 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.22536559 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.20637995 |
| 53 | MP0003075_altered_response_to | 1.19403811 |
| 54 | MP0003186_abnormal_redox_activity | 1.18774193 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.17584130 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.15677842 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.15677842 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.12641418 |
| 59 | MP0002722_abnormal_immune_system | 1.09920213 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.08213523 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.08176218 |
| 62 | MP0010307_abnormal_tumor_latency | 1.07724745 |
| 63 | MP0000604_amyloidosis | 1.07366876 |
| 64 | MP0000858_altered_metastatic_potential | 1.05592286 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 0.99257916 |
| 66 | * MP0009763_increased_sensitivity_to | 0.98899991 |
| 67 | MP0002139_abnormal_hepatobiliary_system | 0.95154762 |
| 68 | MP0003091_abnormal_cell_migration | 0.93019422 |
| 69 | MP0010386_abnormal_urinary_bladder | 0.91062533 |
| 70 | MP0000343_altered_response_to | 0.90602457 |
| 71 | MP0009278_abnormal_bone_marrow | 0.89979762 |
| 72 | MP0001881_abnormal_mammary_gland | 0.88666615 |
| 73 | MP0004883_abnormal_blood_vessel | 0.85238988 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.82558904 |
| 75 | MP0003646_muscle_fatigue | 0.82142594 |
| 76 | MP0008004_abnormal_stomach_pH | 0.79406532 |
| 77 | MP0008874_decreased_physiological_sensi | 0.79386990 |
| 78 | MP0005166_decreased_susceptibility_to | 0.78567077 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76654084 |
| 80 | MP0005390_skeleton_phenotype | 0.76651314 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.75074103 |
| 82 | MP0005164_abnormal_response_to | 0.69221872 |
| 83 | MP0001873_stomach_inflammation | 0.68865020 |
| 84 | MP0001663_abnormal_digestive_system | 0.68840888 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.65897619 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.63849569 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.63810567 |
| 88 | MP0000920_abnormal_myelination | 0.63544374 |
| 89 | MP0004381_abnormal_hair_follicle | 0.63426427 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.63408664 |
| 91 | MP0008260_abnormal_autophagy | 0.62788183 |
| 92 | MP0001851_eye_inflammation | 0.62064317 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.61977326 |
| 94 | MP0000627_abnormal_mammary_gland | 0.60014484 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.58795927 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 0.57958073 |
| 97 | MP0003690_abnormal_glial_cell | 0.57118202 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.56797629 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.54250509 |
| 100 | MP0006054_spinal_hemorrhage | 0.53725522 |
| 101 | MP0002396_abnormal_hematopoietic_system | 0.53557547 |
| 102 | MP0003828_pulmonary_edema | 0.52250403 |
| 103 | MP0000371_diluted_coat_color | 0.52160966 |
| 104 | MP0005174_abnormal_tail_pigmentation | 0.51897536 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.51762556 |
| 106 | MP0000609_abnormal_liver_physiology | 0.51602021 |
| 107 | MP0000249_abnormal_blood_vessel | 0.50866709 |
| 108 | MP0000490_abnormal_crypts_of | 0.50853998 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.49439106 |
| 110 | MP0005023_abnormal_wound_healing | 0.47859281 |
| 111 | MP0002132_abnormal_respiratory_system | 0.47645230 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.46536245 |
| 113 | MP0003866_abnormal_defecation | 0.43683832 |
| 114 | MP0002933_joint_inflammation | 0.43209994 |
| 115 | MP0004858_abnormal_nervous_system | 0.43170898 |
| 116 | MP0003045_fibrosis | 0.43160034 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.43034068 |
| 118 | MP0008057_abnormal_DNA_replication | 0.42015417 |
| 119 | MP0003795_abnormal_bone_structure | 0.40307586 |
| 120 | MP0001915_intracranial_hemorrhage | 0.37639289 |
| 121 | MP0009115_abnormal_fat_cell | 0.36190475 |
| 122 | MP0005535_abnormal_body_temperature | 0.35735625 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.35596354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 6.40996433 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.04288742 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.93254345 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.78737176 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 5.39278878 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.08942191 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.03346507 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.79566391 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.67696682 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.65602892 |
| 11 | Optic neuritis (HP:0100653) | 4.65602892 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.56287732 |
| 13 | Vasculitis (HP:0002633) | 4.52072967 |
| 14 | Orchitis (HP:0100796) | 4.42554953 |
| 15 | Basal ganglia calcification (HP:0002135) | 4.42228862 |
| 16 | Myositis (HP:0100614) | 4.32323391 |
| 17 | Hypergammaglobulinemia (HP:0010702) | 4.29945800 |
| 18 | Chronic otitis media (HP:0000389) | 4.18844449 |
| 19 | Recurrent viral infections (HP:0004429) | 4.01439476 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.96024506 |
| 21 | Recurrent skin infections (HP:0001581) | 3.78882023 |
| 22 | Gastrointestinal stroma tumor (HP:0100723) | 3.68920078 |
| 23 | Porencephaly (HP:0002132) | 3.65639296 |
| 24 | Tetraparesis (HP:0002273) | 3.54386394 |
| 25 | Periodontitis (HP:0000704) | 3.52577256 |
| 26 | Gingivitis (HP:0000230) | 3.44522240 |
| 27 | Encephalitis (HP:0002383) | 3.33216910 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.30013587 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.22973271 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.16410386 |
| 31 | Colitis (HP:0002583) | 3.12025958 |
| 32 | Prostate neoplasm (HP:0100787) | 3.09773714 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.09359010 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.09359010 |
| 35 | Abnormality of glycolipid metabolism (HP:0010969) | 3.09359010 |
| 36 | Arterial thrombosis (HP:0004420) | 3.03520790 |
| 37 | Autoimmune hemolytic anemia (HP:0001890) | 2.99505544 |
| 38 | Stomatitis (HP:0010280) | 2.98288241 |
| 39 | Premature loss of primary teeth (HP:0006323) | 2.97566926 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95918791 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95918791 |
| 42 | Nasal polyposis (HP:0100582) | 2.93375800 |
| 43 | Lymphopenia (HP:0001888) | 2.88516264 |
| 44 | Gingival bleeding (HP:0000225) | 2.86089948 |
| 45 | Hemoptysis (HP:0002105) | 2.85952849 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85583041 |
| 47 | Obstructive lung disease (HP:0006536) | 2.85583041 |
| 48 | Emphysema (HP:0002097) | 2.77151710 |
| 49 | Cleft eyelid (HP:0000625) | 2.76981248 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.75014991 |
| 51 | Panhypogammaglobulinemia (HP:0003139) | 2.74163981 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.73888496 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.69267056 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.68360073 |
| 55 | Thick nail (HP:0001805) | 2.66433348 |
| 56 | Eosinophilia (HP:0001880) | 2.66129091 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.65254584 |
| 58 | Recurrent pneumonia (HP:0006532) | 2.64729459 |
| 59 | Leukocytosis (HP:0001974) | 2.63162403 |
| 60 | Gastrointestinal inflammation (HP:0004386) | 2.62907946 |
| 61 | Joint swelling (HP:0001386) | 2.58388138 |
| 62 | IgM deficiency (HP:0002850) | 2.56914865 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.56641826 |
| 64 | Meningitis (HP:0001287) | 2.51423109 |
| 65 | Abnormality of the nasal mucosa (HP:0000433) | 2.47345665 |
| 66 | IgA deficiency (HP:0002720) | 2.47196693 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.45929976 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.45733546 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45706241 |
| 70 | Vertebral compression fractures (HP:0002953) | 2.43013090 |
| 71 | Cellulitis (HP:0100658) | 2.42626634 |
| 72 | Amaurosis fugax (HP:0100576) | 2.42523373 |
| 73 | Abnormality of the endocardium (HP:0004306) | 2.41764633 |
| 74 | Restrictive lung disease (HP:0002091) | 2.39605131 |
| 75 | Plagiocephaly (HP:0001357) | 2.38898883 |
| 76 | Axonal loss (HP:0003447) | 2.38896444 |
| 77 | Urticaria (HP:0001025) | 2.38665362 |
| 78 | Pustule (HP:0200039) | 2.38147632 |
| 79 | Chronic sinusitis (HP:0011109) | 2.37903618 |
| 80 | Abnormality of the pericardium (HP:0001697) | 2.36977609 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.35360142 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.34794073 |
| 83 | Myocardial infarction (HP:0001658) | 2.33996698 |
| 84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32636530 |
| 85 | Pulmonary embolism (HP:0002204) | 2.32560340 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 2.31610080 |
| 87 | Abnormality of B cell number (HP:0010975) | 2.31440172 |
| 88 | Cheilitis (HP:0100825) | 2.31046523 |
| 89 | IgG deficiency (HP:0004315) | 2.30848504 |
| 90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29137091 |
| 91 | Anorexia (HP:0002039) | 2.27676438 |
| 92 | Gangrene (HP:0100758) | 2.27546761 |
| 93 | Increased IgE level (HP:0003212) | 2.26933962 |
| 94 | Petechiae (HP:0000967) | 2.26081961 |
| 95 | Skin ulcer (HP:0200042) | 2.25627744 |
| 96 | Chest pain (HP:0100749) | 2.24589653 |
| 97 | Osteomyelitis (HP:0002754) | 2.23539083 |
| 98 | Bone pain (HP:0002653) | 2.23151094 |
| 99 | Peritonitis (HP:0002586) | 2.19900785 |
| 100 | Granulocytopenia (HP:0001913) | 2.19635912 |
| 101 | Osteolytic defects of the hand bones (HP:0009699) | 2.19215392 |
| 102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19215392 |
| 103 | Skin rash (HP:0000988) | 2.16656980 |
| 104 | Sepsis (HP:0100806) | 2.16186569 |
| 105 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14376428 |
| 106 | Arthralgia (HP:0002829) | 2.13243288 |
| 107 | Thrombocytosis (HP:0001894) | 2.12169765 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.11469228 |
| 109 | Poor head control (HP:0002421) | 2.11053510 |
| 110 | Polyneuropathy (HP:0001271) | 2.11027312 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 2.11019144 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09974435 |
| 113 | Dysostosis multiplex (HP:0000943) | 2.08484755 |
| 114 | Chronic diarrhea (HP:0002028) | 2.08251359 |
| 115 | Abnormality of the basal ganglia (HP:0002134) | 2.07155007 |
| 116 | B lymphocytopenia (HP:0010976) | 2.07121648 |
| 117 | Loss of speech (HP:0002371) | 2.06963593 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.06032171 |
| 119 | Bronchitis (HP:0012387) | 2.05642188 |
| 120 | Progressive visual loss (HP:0000529) | 2.04162194 |
| 121 | Glomerulopathy (HP:0100820) | 2.04098747 |
| 122 | T lymphocytopenia (HP:0005403) | 2.01981019 |
| 123 | Abnormality of the pleura (HP:0002103) | 2.00916034 |
| 124 | Abnormality of T cells (HP:0002843) | 1.99416678 |
| 125 | Nephritis (HP:0000123) | 1.99149145 |
| 126 | Pathologic fracture (HP:0002756) | 1.97838340 |
| 127 | Purpura (HP:0000979) | 1.96351801 |
| 128 | Agammaglobulinemia (HP:0004432) | 1.95727714 |
| 129 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94291062 |
| 130 | Abnormality of T cell physiology (HP:0011840) | 1.92261435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 6.14025770 |
| 2 | TYK2 | 4.66111945 |
| 3 | TBK1 | 3.86830646 |
| 4 | IKBKE | 3.58158590 |
| 5 | RIPK4 | 3.29899409 |
| 6 | JAK3 | 3.23464772 |
| 7 | IKBKB | 3.10550683 |
| 8 | JAK1 | 3.09181014 |
| 9 | IRAK4 | 3.03369360 |
| 10 | MAP3K13 | 2.95789241 |
| 11 | PIM2 | 2.78183083 |
| 12 | PBK | 2.70953742 |
| 13 | PRPF4B | 2.68197736 |
| 14 | CHUK | 2.28703748 |
| 15 | BLK | 2.18610908 |
| 16 | BMPR2 | 2.10377273 |
| 17 | IRAK3 | 1.93291201 |
| 18 | TXK | 1.90940593 |
| 19 | KIT | 1.90875415 |
| 20 | FGFR4 | 1.71750591 |
| 21 | MAP4K1 | 1.62230563 |
| 22 | ARAF | 1.47035506 |
| 23 | EIF2AK2 | 1.45108959 |
| 24 | SYK | 1.42059806 |
| 25 | MST4 | 1.33925125 |
| 26 | TAOK2 | 1.30828489 |
| 27 | TAOK3 | 1.26094610 |
| 28 | PIM1 | 1.25035343 |
| 29 | IRAK1 | 1.24866100 |
| 30 | NEK9 | 1.24811718 |
| 31 | MAP2K3 | 1.23359957 |
| 32 | EPHB1 | 1.22646892 |
| 33 | BMX | 1.22448659 |
| 34 | FGFR3 | 1.14405356 |
| 35 | CDC42BPA | 1.09639454 |
| 36 | CSK | 1.08151057 |
| 37 | STK4 | 1.07781415 |
| 38 | MAP3K3 | 1.06093270 |
| 39 | HCK | 1.05588101 |
| 40 | ITK | 1.05174400 |
| 41 | TNK2 | 1.04801315 |
| 42 | EPHA3 | 1.03304484 |
| 43 | BCR | 1.02290771 |
| 44 | DDR2 | 1.01024195 |
| 45 | RPS6KA4 | 0.99789905 |
| 46 | TAOK1 | 0.97609710 |
| 47 | JAK2 | 0.97043089 |
| 48 | ZAP70 | 0.93810452 |
| 49 | SIK3 | 0.88119924 |
| 50 | IRAK2 | 0.87769255 |
| 51 | TRIB3 | 0.82703346 |
| 52 | ABL2 | 0.81762455 |
| 53 | SMG1 | 0.81328256 |
| 54 | LCK | 0.80416657 |
| 55 | LYN | 0.80098251 |
| 56 | TRPM7 | 0.79952211 |
| 57 | MAPK11 | 0.79493160 |
| 58 | CDK12 | 0.79437452 |
| 59 | HIPK2 | 0.77907819 |
| 60 | MAP3K5 | 0.76021899 |
| 61 | PKN1 | 0.73013336 |
| 62 | PRKCQ | 0.72367647 |
| 63 | STK10 | 0.72141211 |
| 64 | BTK | 0.71536472 |
| 65 | STK24 | 0.71452361 |
| 66 | ERBB3 | 0.70158140 |
| 67 | CSF1R | 0.68523133 |
| 68 | ERN1 | 0.65223923 |
| 69 | MATK | 0.64210236 |
| 70 | MAPK7 | 0.63775094 |
| 71 | STK3 | 0.63129386 |
| 72 | FES | 0.58969391 |
| 73 | PRKCD | 0.58916554 |
| 74 | ADRBK2 | 0.58553029 |
| 75 | MARK3 | 0.57937384 |
| 76 | MST1R | 0.57797876 |
| 77 | TEC | 0.56540832 |
| 78 | ABL1 | 0.52104477 |
| 79 | PDK1 | 0.51890867 |
| 80 | TESK2 | 0.50868048 |
| 81 | YES1 | 0.46732025 |
| 82 | GRK6 | 0.46571244 |
| 83 | DAPK3 | 0.45839690 |
| 84 | SIK2 | 0.44900920 |
| 85 | RPS6KA5 | 0.44304812 |
| 86 | EGFR | 0.43788214 |
| 87 | PIK3CG | 0.43589118 |
| 88 | NME2 | 0.41867579 |
| 89 | CDK4 | 0.40476470 |
| 90 | MOS | 0.38867054 |
| 91 | FGR | 0.38533629 |
| 92 | RPS6KA1 | 0.36620296 |
| 93 | PRKCE | 0.36141832 |
| 94 | FYN | 0.35603060 |
| 95 | RIPK1 | 0.34571719 |
| 96 | NLK | 0.33237796 |
| 97 | SIK1 | 0.33234832 |
| 98 | TGFBR2 | 0.32866609 |
| 99 | RPS6KA6 | 0.32562984 |
| 100 | CAMKK2 | 0.32516230 |
| 101 | PDPK1 | 0.32440193 |
| 102 | PRKD2 | 0.32192214 |
| 103 | MAPKAPK2 | 0.31141880 |
| 104 | TESK1 | 0.30374388 |
| 105 | PLK4 | 0.30204629 |
| 106 | MAP3K12 | 0.28435267 |
| 107 | MARK2 | 0.27644048 |
| 108 | PTK6 | 0.26602672 |
| 109 | ZAK | 0.25763699 |
| 110 | MAPK4 | 0.25635625 |
| 111 | MAPK12 | 0.22958474 |
| 112 | LRRK2 | 0.22596973 |
| 113 | PRKCH | 0.21304450 |
| 114 | INSR | 0.21188261 |
| 115 | GRK7 | 0.20762253 |
| 116 | MELK | 0.20323591 |
| 117 | RPS6KB1 | 0.20093681 |
| 118 | MAP2K6 | 0.17545498 |
| 119 | MAPK3 | 0.17396620 |
| 120 | DAPK2 | 0.15980542 |
| 121 | CLK1 | 0.15873766 |
| 122 | PLK2 | 0.15750235 |
| 123 | MAP3K1 | 0.15536317 |
| 124 | KSR2 | 0.14673221 |
| 125 | MAP3K11 | 0.14478901 |
| 126 | TTN | 0.14165854 |
| 127 | RAF1 | 0.14036123 |
| 128 | IGF1R | 0.14031432 |
| 129 | EPHB2 | 0.13429489 |
| 130 | NUAK1 | 0.12076813 |
| 131 | AKT1 | 0.11697328 |
| 132 | SGK1 | 0.11184328 |
| 133 | CDK6 | 0.10771240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.48492938 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.70737800 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.39810238 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.17769384 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.05631989 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.99967188 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88019386 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.84562509 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.65218293 |
| 10 | * Measles_Homo sapiens_hsa05162 | 2.55650079 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.55011073 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.48768988 |
| 13 | * Influenza A_Homo sapiens_hsa05164 | 2.34805357 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.12518226 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.11946739 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 2.09804930 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.08243336 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.07278804 |
| 19 | Asthma_Homo sapiens_hsa05310 | 2.00598531 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92802764 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.89490289 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88693697 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75928759 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.75456293 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.74882466 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.72358238 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60566922 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60180794 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59758599 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50450557 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44370121 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.43878998 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37293870 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.34645714 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33648869 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24990201 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.24182969 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.23919553 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16525671 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13881873 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.09223525 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99885306 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 0.99730554 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91674962 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89109200 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.84789977 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77164074 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75378050 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.68430696 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66685966 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65216449 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58493092 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58306488 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57875372 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57018805 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.55150527 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52809830 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51966533 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50272227 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47795523 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46317619 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44706114 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42157973 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41079420 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40021765 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39008037 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37579469 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37077016 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35959341 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35794473 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34594636 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.33365874 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32643092 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32633118 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32159168 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.31767238 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30184003 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29874354 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29198906 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28804954 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26014068 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.25716281 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25184102 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24556309 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.23280368 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.22573960 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21499740 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17350948 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14879592 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.14825712 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14681574 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.14425359 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13977351 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13814008 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.13764948 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.12798924 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.12224608 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12094632 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.10168763 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09782447 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09354800 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.08865441 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08702468 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08673858 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08509223 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.07729830 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.07562254 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07251107 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.06060808 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05320422 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05135855 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.03540003 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.01872167 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.01709766 |

